First established in 1869, their story has since been one of constant evolution and innovation - because diseases are an ever-changing, often life-threatening enemy. Centrient is partnering with nature to grow foundational medicines with the quality, reliability and secure supply necessary to stay one step ahead.

Today, Centrient is a company 1800 people strong with operations on four continents. They manufacture a diversified portfolio of intermediaries and active pharmaceutical ingredients (APIs), as well as made-to-order tablets, capsules, and other finished dosage forms (FDFs).

They are working to be better prepared for the ever-changing: they continue to diversify their portfolio and develop their biotechnology capabilities, transitioning from a manufacturer to an innovation partner for our markets. Centrient will keep doing whatever is needed to protect and improve billions of people’s lives, for years to come.